Northwire Canada EditionFriday, July 17, 2026
Northwire
LUN 33.59 −2.5% NTR 94.27 −1.8% LALI 0.055 −8.3% SCD 0.170 +0.0% HWY 0.370 +0.0% FCI 0.385 +1.3% GGAU 0.180 −5.3% KIRO 0.650 +1.6% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.095 −5.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.55 +1.8% LUN 33.59 −2.5% NTR 94.27 −1.8% LALI 0.055 −8.3% SCD 0.170 +0.0% HWY 0.370 +0.0% FCI 0.385 +1.3% GGAU 0.180 −5.3% KIRO 0.650 +1.6% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.095 −5.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.55 +1.8%
Other

Cannabix Secures First Distributor Order for BreathLogix Alcohol Screening Devices in Australia

BLO · Price

Executive Summary

  • Cannabix Technologies received its first international distributor orders for BreathLogix alcohol screening devices from exclusive Australian partner Breathalyser Sales & Service Pty Ltd.
  • The order marks the inaugural sales of the BreathLogix product line outside North America, covering Australia, New Zealand and the Pacific Islands.
  • The company announced it will not proceed with the previously disclosed non‑brokered LIFE private placement and will reassess near‑term capital requirements in early 2026.

Key Details

  • First International Distributor Order: Breathalyser Sales & Service Pty Ltd (Breathalyser SSP) placed initial orders for BreathLogix devices and accessories.
  • Geographic Coverage: The exclusive distribution agreement with Breathalyser SSP covers Australia, New Zealand and the Pacific Islands.
  • Product Highlights: BreathLogix provides rapid breath‑alcohol testing, simultaneous photo capture, real‑time alerts via SMS/email, cloud reporting, and integration capability with access control systems.
  • Target Sectors: Mining, oil & gas, industrial, trucking, warehousing, technology, and other employer groups in the Australian market.
  • CEO Comment: “Cannabix is excited to receive first orders from Australia for its BreathLogix Alcohol devices as the Company works to deliver innovative new technologies to market.” – Rav Mlait, CEO.
  • Partner Quote: “BreathLogix delivers several key features that are important to employers… Pre‑access, unmanned employee alcohol screening is a major segment of our business.” – Ben Smit, Managing Director, Breathalyser SSP.
  • Financing Update: The company will not move forward with the previously announced non‑brokered LIFE private placement; capital needs will be reassessed in early 2026.
  • Investor Awareness Campaign: Cannabix entered a 30‑day campaign with ShareholdersIPR LLC, paying USD 2,450 for research and dissemination services (no securities issued as compensation).

Notable Quotes

“Cannabix is excited to receive first orders from Australia for its BreathLogix Alcohol devices as the Company works to deliver innovative new technologies to market.” – Rav Mlait, CEO, Cannabix Technologies Inc.

“BreathLogix delivers several key features that are important to employers… Pre‑access, unmanned employee alcohol screening is a major segment of our business.” – Ben Smit, Managing Director, Breathalyser Sales & Service Pty Ltd.

Read the original news release →

More from Cannabix Technologies Inc.